TCM
BSX icon

Traynor Capital Management’s Boston Scientific BSX Stock Holding History

Traynor Capital Management’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-21,214
Closed -$1.33M – 373
2026
Q1 		$1.33M Sell
21,214
-3,803
-15% -$304K 0.08% 111
2025
Q4 		$2.39M Buy
25,017
+293
+1% +$28.7K 0.13% 81
2025
Q3 		$2.41M Buy
+24,724
New +$2.56M 0.14% 73
2020
Q4 		– Sell
-6,475
Closed -$240K – 160
2020
Q3 		$240K Sell
6,475
-1,450
-18% -$55.9K 0.05% 127
2020
Q2 		$278K Buy
+7,925
New +$285K 0.07% 122

Other funds holding BSX

Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
ATO
Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return
RG
Rathbones Group Liverpool, United Kingdom $27.1B AUM 20.2% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
BPC
Banque Pictet & Cie Geneva 73, Switzerland $16B AUM 29.1% 1-Year Est. Return
FFM
Fisher Funds Management Auckland, New Zealand $3.52B AUM 17.59% 1-Year Est. Return
BPCE
Bank Pictet & Cie (Europe) Frankfurt Am Main, Germany $5.12B AUM 27.39% 1-Year Est. Return

Traynor Capital Management's BSX Position: Q2 2026 in Review

Traynor Capital Management sold out of Boston Scientific (BSX) in Q2 2026, closing a stake of 21,214 shares — an estimated $1.33M sold.

Traynor Capital Management first reported a position in BSX in Q2 2020 and held it in 5 quarters. The position peaked at $2.41M in Q3 2025. 323 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Traynor Capital Management reported no remaining Boston Scientific position as of Q2 2026 after selling out during the quarter.
  • Traynor Capital Management sold 21,214 Boston Scientific shares in Q2 2026, an estimated $1.33M.
  • Traynor Capital Management first reported a position in Boston Scientific in Q2 2020 and held it in 5 quarters.
  • Traynor Capital Management's Boston Scientific position peaked at $2.41M in Q3 2025.
  • 323 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Traynor Capital Management's 13F filing for Q2 2026, filed 22 Jul 2026.